Schrödinger, Inc. (SDGR)
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?
Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?
Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript
Schrödinger, Inc. (SDGR) Q2 2026 Earnings Call Transcript
Schrodinger Q2 Earnings Call Highlights
Schrodinger NASDAQ: SDGR said second-quarter annual contract value growth accelerated as demand broadened across large pharmaceutical customers, biotechnology companies and materials-science customers, while the company launched early access for Bunsen, its agentic AI co-scientist.
Schrodinger, Inc. (SDGR) Q2 Earnings and Revenues Top Estimates
Schrodinger, Inc. (SDGR) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of a loss of $0.6 per share. This compares to a loss of $0.59 per share a year ago.
Schrodinger: A Rare AI-Adjacent Disruptor Still Not Priced For It
Schrödinger is challenging the incumbent drug-trial method—physics-simulated molecular design that cuts the cost, time, and animal testing of building and screening thousands of candidates. The current EV is roughly accounted for by the software leg alone - the royalties business and the disruption TAM are barely priced in, if at all. Three drivers - a regulatory push away from animal testing, AI-led consumption growth, and Bunsen - open up asymmetric upside that is not required for the base case.
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Schrödinger, Inc. (SDGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Schrödinger, Inc. (SDGR) Q1 2026 Earnings Call Transcript
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to a loss of $0.82 per share a year ago.
Schrodinger Inc (SDGR) Shares Fall 4.1% -- What GF Score of 69 Tells Investors
On April 22, 2026, Schrodinger Inc (SDGR) shares fell 4.1% today, bringing the current price to $12.35. The stock has experienced a 52-week range between $10.95
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Schrödinger, Inc. (SDGR) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
